{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T14:51:53Z","timestamp":1787237513489,"version":"build-2736575974"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T00:00:00Z","timestamp":1751500800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100013043","name":"Ariel University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013043","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neoplasia"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.neo.2025.101208","type":"journal-article","created":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T19:19:06Z","timestamp":1752607146000},"page":"101208","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Biphasic behavior of T cell subsets reflects failure of early anti-myeloma response and leads to progressive T cell dysfunction"],"prefix":"10.1016","volume":"67","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6565-8335","authenticated-orcid":false,"given":"Suchita Suryakant","family":"Jadhav","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vipin","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aharon","family":"Lion","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lasser-Katz","family":"Efrat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iftach","family":"Shaked","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Galia","family":"Luboshits","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8430-0486","authenticated-orcid":false,"given":"Michael A.","family":"Firer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neo.2025.101208_bib0001","doi-asserted-by":"crossref","first-page":"3111","DOI":"10.1038\/s41375-020-01051-x","article-title":"Changing paradigms in diagnosis and treatment of monoclonal gammopathy of undetermined significance (MGUS) and smoldering multiple myeloma (SMM)","author":"Ho","year":"2020","journal-title":"Leukemia"},{"key":"10.1016\/j.neo.2025.101208_bib0002","doi-asserted-by":"crossref","first-page":"5573","DOI":"10.1182\/blood-2011-01-270140","article-title":"Monoclonal gammopathy of undetermined significance (MGUS) and smoldering multiple myeloma (SMM): novel biological insights and development of early treatment strategies","volume":"117","author":"Korde","year":"2011","journal-title":"Blood [Internet]"},{"key":"10.1016\/j.neo.2025.101208_bib0003","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1002\/ajh.25791","article-title":"Multiple myeloma: 2020 update on diagnosis, risk-stratification and management","volume":"95","author":"Rajkumar","year":"2020","journal-title":"Am. J. Hematol. [Internet]"},{"key":"10.1016\/j.neo.2025.101208_bib0004","series-title":"The immune microenvironment of myeloma","first-page":"313","author":"Noonan","year":"2011"},{"key":"10.1016\/j.neo.2025.101208_bib0005","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1038\/s41568-024-00755-x","article-title":"New horizons in our understanding of precursor multiple myeloma and early interception","volume":"24","author":"Cordas dos Santos","year":"2024","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.neo.2025.101208_bib0006","article-title":"Co-evolution of tumor and immune cells during progression of multiple myeloma","volume":"12","author":"Liu","year":"2021","journal-title":"Nat. Commun"},{"key":"10.1016\/j.neo.2025.101208_bib0007","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1158\/2767-9764.CRC-22-0022","article-title":"Comprehensive characterization of the Multiple myeloma immune microenvironment using integrated scRNA-seq, CyTOF, and CITE-seq analysis","volume":"2","author":"Yao","year":"2022","journal-title":"Cancer Res. Commun."},{"issue":"Suppl 2","key":"10.1016\/j.neo.2025.101208_bib0008","article-title":"The immune system in multiple myeloma and precursor states: lessons and implications for immunotherapy and interception","volume":"98","author":"Dhodapkar","year":"2023","journal-title":"Am. J. Hematol. [Internet]"},{"key":"10.1016\/j.neo.2025.101208_bib0009","first-page":"1","article-title":"T cells in multiple myeloma display features of exhaustion and senescence at the tumor site","volume":"9","author":"Zelle-Rieser","year":"2016","journal-title":"J. Hematol. Oncol. [Internet]"},{"key":"10.1016\/j.neo.2025.101208_bib0010","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13133213","article-title":"Mechanisms of immune evasion in multiple myeloma: open questions and therapeutic opportunities","author":"Botta","year":"2021","journal-title":"Cancers (Basel). MDPI"},{"key":"10.1016\/j.neo.2025.101208_bib0011","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.3109\/10428194.2013.825905","article-title":"Myeloma skews regulatory T and pro-inflammatory T helper 17 cell balance in favor of a suppressive state","volume":"55","author":"Favaloro","year":"2014","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.neo.2025.101208_bib0012","doi-asserted-by":"crossref","first-page":"3443","DOI":"10.1158\/1078-0432.CCR-19-1714","article-title":"Marrow-infiltrating regulatory T cells correlate with the presence of dysfunctional CD4\u00fePD-1\u00fe cells and inferior survival in patients with newly diagnosed multiple myeloma","volume":"26","author":"Alrasheed","year":"2020","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.neo.2025.101208_bib0013","doi-asserted-by":"crossref","first-page":"2134","DOI":"10.1080\/10428194.2019.1579324","article-title":"Evaluating the role of tregs in the progression of multiple myeloma","volume":"60","author":"Lad","year":"2019","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.neo.2025.101208_bib0014","first-page":"1","article-title":"T cells in multiple myeloma display features of exhaustion and senescence at the tumor site","volume":"9","author":"Zelle-Rieser","year":"2016","journal-title":"J. Hematol. Oncol. [Internet]"},{"key":"10.1016\/j.neo.2025.101208_bib0015","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0051892","article-title":"A novel mouse model for multiple myeloma (MOPC315.BM) that allows noninvasive spatiotemporal detection of osteolytic disease","volume":"7","author":"Hofgaard","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.neo.2025.101208_bib0016","article-title":"Tracking the cellular immune response from early premalignancy to active multiple myeloma in a new model","volume":"54","author":"Jadhav","year":"2024","journal-title":"Eur. J. Immunol. [Internet]"},{"key":"10.1016\/j.neo.2025.101208_bib0017","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1186\/s40425-019-0776-9","article-title":"Long-term survival without graft-versus-host-disease following infusion of allogeneic myeloma-specific v\u03b2 T cell families","volume":"7","author":"Yado","year":"2019","journal-title":"J. Immunother. Cancer [Internet]"},{"key":"10.1016\/j.neo.2025.101208_bib0018","doi-asserted-by":"crossref","first-page":"5242","DOI":"10.3390\/ijms23095242","article-title":"The role of T cell immunity in monoclonal gammopathy and multiple myeloma: from immunopathogenesis to novel therapeutic approaches","volume":"23","author":"Lagreca","year":"2022","journal-title":"Int. J. Mol. Sci. [Internet]"},{"key":"10.1016\/j.neo.2025.101208_bib0019","first-page":"3954","article-title":"The yin\u2013yang effects of immunity: from monoclonal gammopathy of undetermined significance to multiple myeloma","author":"Yi","year":"2022","journal-title":"Front Immunol. Front. Media S.A"},{"key":"10.1016\/j.neo.2025.101208_bib0020","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1053\/j.seminhematol.2024.11.003","article-title":"Immunocompetent mouse models of multiple myeloma","volume":"62","author":"Bergsagel","year":"2025","journal-title":"Semin. Hematol. [Internet]"},{"key":"10.1016\/j.neo.2025.101208_bib0021","doi-asserted-by":"crossref","first-page":"79","DOI":"10.3324\/haematol.2012.067272","article-title":"Analysis of the immune system of multiple myeloma patients achieving long-term disease control by multidimensional flow cytometry","volume":"98","author":"de Magalh\u00e3es","year":"2013","journal-title":"Haematol. [Internet]"},{"key":"10.1016\/j.neo.2025.101208_bib0022","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/9271469","article-title":"Circulating regulatory T-cells in monoclonal gammopathies of uncertain significance and multiple myeloma: in search of a role","author":"D\u2019arena","year":"2016","journal-title":"J. Immunol. Res. [Internet]"},{"key":"10.1016\/j.neo.2025.101208_bib0023","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1186\/s12935-018-0687-8","article-title":"Increased activated regulatory T cell subsets and aging treg-like cells in multiple myeloma and monoclonal gammopathy of undetermined significance: a case control study","volume":"18","author":"Wang","year":"2018","journal-title":"Cancer Cell. Int. [Internet]"},{"key":"10.1016\/j.neo.2025.101208_bib0024","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1007\/s10753-014-9980-4","article-title":"The alteration and clinical significance of Th1\/Th2\/Th17\/treg cells in patients with multiple myeloma","volume":"38","author":"Feng","year":"2015","journal-title":"Inflammation"},{"key":"10.1016\/j.neo.2025.101208_bib0025","doi-asserted-by":"crossref","first-page":"3213","DOI":"10.3390\/cancers13133213","article-title":"Mechanisms of immune evasion in multiple myeloma: open questions and therapeutic opportunities [Internet]","author":"Botta","year":"2021","journal-title":"Cancers (Basel). MDPI"},{"key":"10.1016\/j.neo.2025.101208_bib0026","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/314620","article-title":"Th17 Cell plasticity and functions in cancer immunity","author":"Gu\u00e9ry","year":"2015","journal-title":"Biomed. Res. Int. Hindawi Publ. Corp."},{"key":"10.1016\/j.neo.2025.101208_bib0027","article-title":"Treg and oligoclonal expansion of terminal effector CD8+ T cell as key players in multiple myeloma","volume":"12","author":"Joshua","year":"2021","journal-title":"Front. Immunol. [Internet]"},{"key":"10.1016\/j.neo.2025.101208_bib0028","article-title":"Dissecting molecular mechanisms of immune microenvironment dysfunction in multiple myeloma and precursor conditions","volume":"9","author":"Moscvin","year":"2023","journal-title":"J. Cancer Metastasis Treat."},{"key":"10.1016\/j.neo.2025.101208_bib0029","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2021-003572","article-title":"Neoantigen vaccine-induced CD4 T cells confer protective immunity in a mouse model of multiple myeloma through activation of CD8 T cells against non-vaccine, tumor-associated antigens","volume":"10","author":"Bekri","year":"2022","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.neo.2025.101208_bib0030","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1158\/1078-0432.CCR-19-2111","article-title":"How to train your T cells: overcoming immune dysfunction in multiple myeloma a C","volume":"26","author":"Cohen","year":"2020","journal-title":"Clin. Cancer Res. [Internet]"},{"key":"10.1016\/j.neo.2025.101208_bib0031","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e33091","article-title":"Pathways to therapy resistance: the sheltering effect of the bone marrow microenvironment to multiple myeloma cells","volume":"10","author":"Bhowmick","year":"2024","journal-title":"Heliyon"},{"key":"10.1016\/j.neo.2025.101208_bib0032","first-page":"1","article-title":"The correlation between the Th17\/treg cell balance and bone health","volume":"17","author":"Zhu","year":"2020","journal-title":"Immun. Ageing [Internet]"},{"key":"10.1016\/j.neo.2025.101208_bib0033","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms9983","article-title":"Osteoclasts control reactivation of dormant myeloma cells by remodelling the endosteal niche","volume":"6","author":"Lawson","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.neo.2025.101208_bib0034","first-page":"214","article-title":"Understanding subset diversity in T cell memory","author":"Jameson","year":"2018","journal-title":"Immun. Cell Press;"},{"key":"10.1016\/j.neo.2025.101208_bib0035","series-title":"T cell memory in infection, cancer, and autoimmunity","author":"Barnaba","year":"2022"},{"key":"10.1016\/j.neo.2025.101208_bib0036","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1007\/s13238-020-00707-9","article-title":"Memory T cells: strategies for optimizing tumor immunotherapy","author":"Liu","year":"2020","journal-title":"Protein Cell"},{"key":"10.1016\/j.neo.2025.101208_bib0037","doi-asserted-by":"crossref","DOI":"10.1016\/j.smim.2020.101435","article-title":"Memory CD8+ T cell responses to cancer","author":"Han","year":"2020","journal-title":"Semin. Immunol."},{"key":"10.1016\/j.neo.2025.101208_bib0038","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abo5871","article-title":"The evolving role of tissue-resident memory T cells in infections and cancer","author":"Yenyuwadee","year":"2022","journal-title":"Sci. Adv."},{"key":"10.1016\/j.neo.2025.101208_bib0039","doi-asserted-by":"crossref","first-page":"907","DOI":"10.4049\/jimmunol.2300049","article-title":"Memory T cells in the immunoprevention of cancer: a switch from therapeutic to prophylactic approaches","volume":"211","author":"Mittra","year":"2023","journal-title":"J. Immunol. [Internet]"},{"key":"10.1016\/j.neo.2025.101208_bib0040","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.it.2019.06.002","article-title":"Tissue-resident memory T cells in cancer immunosurveillance","author":"Park","year":"2019","journal-title":"Trends Immunol."},{"key":"10.1016\/j.neo.2025.101208_bib0041","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1038\/s41577-020-0306-5","article-title":"A guide to cancer immunotherapy: from T cell basic science to clinical practice","volume":"20","author":"Waldman","year":"2020","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.neo.2025.101208_bib0042","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1007\/s10555-024-10212-8","article-title":"Natural killer cells in neuroblastoma: immunological insights and therapeutic perspectives","volume":"43","author":"Rados","year":"2024","journal-title":"Cancer Metastasis Rev. [Internet]"},{"key":"10.1016\/j.neo.2025.101208_bib0043","first-page":"15","article-title":"The basic biology of NK cells and its application in tumor immunotherapy","author":"Jiang","year":"2024","journal-title":"Front Immunol."},{"key":"10.1016\/j.neo.2025.101208_bib0044","article-title":"Cross-talks between natural killer cells and distinct subsets of dendritic cells","volume":"5","author":"Ferlazzo","year":"2014","journal-title":"Front Immunol. [Internet]"},{"key":"10.1016\/j.neo.2025.101208_bib0045","article-title":"Natural killer cells and regulatory T cells cross talk in hepatocellular carcinoma: exploring therapeutic options for the next decade","volume":"12","author":"Bozward","year":"2021","journal-title":"Front Immunol. [Internet]"},{"key":"10.1016\/j.neo.2025.101208_bib0046","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1444821","article-title":"Type I-conventional dendritic cells support the progression of multiple myeloma in the bone marrow","volume":"15","author":"Suzuki","year":"2024","journal-title":"Front Immunol."},{"key":"10.1016\/j.neo.2025.101208_bib0047","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-018-05058-y","article-title":"Genomic patterns of progression in smoldering multiple myeloma","volume":"9","author":"Bolli","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.neo.2025.101208_bib0048","doi-asserted-by":"crossref","DOI":"10.3390\/cancers16030498","article-title":"Novel insights into the initiation, evolution, and progression of multiple myeloma by Multi-omics investigation","author":"Gong","year":"2024","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.neo.2025.101208_bib0049","first-page":"1","article-title":"A single-cell transcriptomic map of the murine and human multiple myeloma immune microenvironment across disease stages","volume":"17","author":"Verheye","year":"2024","journal-title":"J. Hematol. Oncol. 2024 17:1 [Internet]"},{"key":"10.1016\/j.neo.2025.101208_bib0050","first-page":"1","article-title":"Multi-omics reveal immune microenvironment alterations in multiple myeloma and its precursor stages","volume":"14","author":"Cheng","year":"2024","journal-title":"Blood Cancer J. 2024 14:1 [Internet]"}],"container-title":["Neoplasia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1476558625000880?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1476558625000880?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,28]],"date-time":"2025-07-28T07:09:16Z","timestamp":1753686556000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1476558625000880"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":50,"alternative-id":["S1476558625000880"],"URL":"https:\/\/doi.org\/10.1016\/j.neo.2025.101208","relation":{},"ISSN":["1476-5586"],"issn-type":[{"value":"1476-5586","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Biphasic behavior of T cell subsets reflects failure of early anti-myeloma response and leads to progressive T cell dysfunction","name":"articletitle","label":"Article Title"},{"value":"Neoplasia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neo.2025.101208","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"101208"}}